4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bolt Biotherapeutics, Inc. (BOLT) operates in the Biotechnology industry and is headquartered in Redwood City, United States. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-12-31, BOLT reported $8M in revenue and ($33M) in net income.
Bolt Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer.
Interactive charts & full statements → Open the BOLT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $8M | $8M | $6M | — |
| Operating Income (EBIT) | ($36M) | ($73M) | ($76M) | ($90M) | — |
| Net Income | ($33M) | ($63M) | ($69M) | ($88M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $2M | $2M | $2M |
| Operating Income (EBIT) | ($8M) | ($8M) | ($7M) | ($8M) | ($9M) |
| Net Income | ($8M) | ($7M) | ($7M) | ($7M) | ($9M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $57M | $100M | $160M | $228M | — |
| Total Liabilities | $30M | $42M | $47M | $56M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BOLT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms